- Previous Close
3.0000 - Open
3.0500 - Bid 2.7500 x --
- Ask --
- Day's Range
3.0000 - 3.0500 - 52 Week Range
0.7500 - 7.5000 - Volume
200 - Avg. Volume
936 - Market Cap (intraday)
75.568M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0500 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
ME Therapeutics Holdings Inc., a preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology. The company was incorporated in 2021 and is headquartered in Vancouver, Canada.
www.metherapeutics.comRecent News: METX.CN
View MorePerformance Overview: METX.CN
Trailing total returns as of 12/27/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: METX.CN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: METX.CN
View MoreValuation Measures
Market Cap
75.57M
Enterprise Value
75.23M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
51.21
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
-0.0500
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--